These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 25724135)
21. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
23. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation. Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168 [TBL] [Abstract][Full Text] [Related]
24. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
25. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Giovino C; Ayensu I; Tetteh J; Boateng JS Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987 [TBL] [Abstract][Full Text] [Related]
26. PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency. Yu F; Ao M; Zheng X; Li N; Xia J; Li Y; Li D; Hou Z; Qi Z; Chen XD Drug Deliv; 2017 Nov; 24(1):825-833. PubMed ID: 28509588 [TBL] [Abstract][Full Text] [Related]
27. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles. Joshi G; Kumar A; Sawant K Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453 [TBL] [Abstract][Full Text] [Related]
28. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Sonaje K; Lin KJ; Wey SP; Lin CK; Yeh TH; Nguyen HN; Hsu CW; Yen TC; Juang JH; Sung HW Biomaterials; 2010 Sep; 31(26):6849-58. PubMed ID: 20619787 [TBL] [Abstract][Full Text] [Related]
29. Long-circulating poly(ethylene glycol)-coated poly(lactid-co-glycolid) microcapsules as potential carriers for intravenously administered drugs. Ferenz KB; Waack IN; Mayer C; de Groot H; Kirsch M J Microencapsul; 2013; 30(7):632-42. PubMed ID: 23489015 [TBL] [Abstract][Full Text] [Related]
30. Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats. Sharma R; Gupta U; Garg NK; Tyagi RK; Jain NK Colloids Surf B Biointerfaces; 2015 Mar; 127():172-81. PubMed ID: 25679489 [TBL] [Abstract][Full Text] [Related]
31. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density. Essa S; Rabanel JM; Hildgen P Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551 [TBL] [Abstract][Full Text] [Related]
37. Surface functional modification of self-assembled insulin nanospheres for improving intestinal absorption. Shi K; Fang Y; Kan Q; Zhao J; Gan Y; Liu Z Int J Biol Macromol; 2015 Mar; 74():49-60. PubMed ID: 25433129 [TBL] [Abstract][Full Text] [Related]
38. Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection. Xie B; Liu Y; Guo Y; Zhang E; Pu C; He H; Yin T; Tang X Pharm Res; 2018 Feb; 35(3):62. PubMed ID: 29445971 [TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB. Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073 [TBL] [Abstract][Full Text] [Related]
40. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]